GoldenBiotech Signed MOU with BNC Korea for Cooperation and Licensing of Covid-19 New Drug Antroquinonol in South Korea. Read More » August 27, 2020
BIO Asia Taiwan 2020 Exhibition Highlights-“GoldenBiotech Can Help!” Featuring Progress of Antroquinonol on COVID-19 Phase 2 Trial in USA Read More » July 29, 2020
The Associated Press- Anti-viral and Anti-Inflammatory Response: GoldenBiotech’s Antroquinonol Receives FDA Approval on COVID-19 Phase 2 Trial in USA Read More » July 1, 2020
Bloomberg- Anti-viral and Anti-Inflammatory Response: GoldenBiotech’s Antroquinonol Receives FDA Approval on COVID-19 Phase 2 Trial in USA Read More » July 1, 2020
Anti-viral and Anti-Inflammatory Response: GoldenBiotech’s Antroquinonol Receives FDA Approval on COVID-19 Phase 2 Trial in USA Read More » July 1, 2020
